With Close to 30 Years of Experience in the IOL Field, I-MED Pharma Continues to Offer Ophthalmologists the Most Suitable Tools to Treat Patients Suffering from Cataracts.
INTRAOCULAR LENSES (IOLS)
I-MED Pharma’s wide range of IOLs give surgeons unmatched flexibility to meet their patients’ needs.
In Canada, I-MED Pharma is the exclusive distributor for Rayner, the world’s first intraocular lens manufacturer. Rayner’s IOLs include the most advanced design and materials available, ensuring excellent surgical results. Complementing this line, I-MED Pharma’s own PMMA and silicone line give ophthalmologists and cataract patients a full range of choices for cataract surgery.
Rayner Intraocular Lenses
In 1949, British surgeon Sir Harold Ridley asked Rayner to design and produce the first IOL. Since this pioneering work in the restoration of sight, Rayner has worked with surgeons around the world in the continued development of the IOL.
C-flex® and Superflex® Aspheric Monofocal IOL
Built on the proven Rayner Primary IOL Platform, the C-flex Aspheric and Superflex Aspheric are hydrophilic acrylic aspheric monofocal IOLs with a 360° enhanced square edge and true aberration-neutral optic technology. The Rayner C-flex Aspheric and Superflex Aspheric lenses are aberration neutral, allowing patients to benefit from the natural residual positive aberration of the cornea.
- C-flex Aspheric is the 5.75 mm diameter monofocal optic, manufactured in powers from +8.0 to +34.0 D.
- Superflex Aspheric is a 6.25 mm diameter monofocal optic, manufactured in powers from -10.0 to +22.0 D.
T-flex® Aspheric Toric IOL
Proven rotational stability2 and excellent centration for predictable, sustainable and accurate visual results make Rayner’s T-flex® Aspheric Toric IOL the ideal choice for treating cataract patients with pre-existing corneal astigmatism.
Anti-Vaulting Haptic (AVH) Technology® – a feature of Rayner’s primary IOL platform, offers excellent fixation within the capsular bag and an extensive range of sphere and cylinder power combinations allowing more patients to be accurately corrected,even those with high levels of corneal astigmatism.